CLINICAL_TRIALS
trial_result
· 2025-12-24
Clinical Trial Update: ALS Phase II Study of NX210c [Phase 2]
Summary
A Phase II clinical trial of NX210c for Amyotrophic Lateral Sclerosis is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Axoltis Pharma | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING